BHU scientists secure patent for Ayurvedic formulation inhibiting over 95% Covid virus growth
BHU researchers at centre for genetic disorders also filed two international patents and received two German patents for related research.
Vagisha Kaushik | September 24, 2024 | 12:48 PM IST
NEW DELHI : Researchers from the centre for genetic orders at Banaras Hindu University (BHU) have achieved a major milestone in the fight against the SARS-CoV-2 virus, securing an Indian patent for an innovative Ayurvedic formulation that combines the phytomolecules of Ashwagandha (Withania somnifera) and Morus alba. This formulation has demonstrated over 95% effectiveness in inhibiting viral growth in cell lines, marking it as a promising candidate for future COVID-19 treatments.
In addition to the Indian patent, the team has filed two international patents and received two German patents for related research. Their relentless efforts, which began in the early days of the pandemic, highlight a promising pathway for inhibiting the growth of SARS-CoV-2, BHU said.
Drawing on the therapeutic properties of these traditional Ayurvedic ingredients, the formulation has shown considerable efficacy in preliminary studies. The next steps will involve testing in animal models, followed by clinical trials to evaluate its effects in humans.
BHU patent
The patent recognizes the efforts of a distinguished team led by professor Parimal Das, alongside PhD scholars Prashant Ranjan, Neha, Chandra Devi, and Prashasti Yadav, as well as Dr Garima Jain (Malaviya Post Doctoral Fellow), Dr Chandana Basu Malick (Wellcome Trust Fellow), and Dr Bhagyalaxmi Mohapatra (department of zoology). This collaborative achievement underscores the potential of Ayurvedic phytomolecules in modern medical research.
Also read 4 private universities ahead of all IITs together in patent applications
Professor Das expressed optimism about the formulation, stating, “This achievement reflects the dedication and hard work of our team. We are hopeful that it can provide a natural solution to combat SARS-CoV-2.”
This groundbreaking discovery, rooted in Ayurvedic science, offers renewed hope in the ongoing global battle against the pandemic and showcases the commitment of young researchers dedicated to this critical project, added the university.
Follow us for the latest education news on colleges and universities, admission, courses, exams, research, education policies, study abroad and more..
To get in touch, write to us at news@careers360.com.
Next Story
]Featured News
]- Empty classrooms, dubious admissions: Murshidabad’s B.Ed college boom a cause for concern
- Stanford University’s list of top scientists must not be misused to win perception battles, says JNU Professor
- NEET Counselling 2024: Close to 1,500 ‘convert’ to NRI quota for MBBS admissions
- RGNUL incident ‘deeply troubling’; alumni, law universities extend support to protesting students
- ‘Constant scrutiny’: RGNUL Patiala VC’s hostel visit sparks protests, demand for resignation
- AIIMS Delhi optometry students protest ‘outdated’ syllabus, hostel shortage, ‘discrimination’
- IISc Bengaluru: Over 800 students, faculty sign petition to cancel 'India-Israel Business Summit'
- NTA owes school principals lakhs in NEET, CUET bills despite Rs 449-crore profit
- India has 2,939 researchers on Stanford University’s list of top 2% scientists, a fifth of China’s 10,687
- Canada to cut international student permits by 10% in 2025; brings new language norms